KYMERA THERAPEUTICS, INC. Debt Securities, Available-for-sale, Noncurrent
KYMERA THERAPEUTICS, INC. (KYMR) had Debt Securities, Available-for-sale, Noncurrent of $813.90 million as of 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:AvailableForSaleSecuritiesDebtSecuritiesNoncurrent · last filed 2026-08-05
- 2026-06-30: Debt Securities, Available-for-sale, Noncurrent $813.90M.
- 2026-03-31: Debt Securities, Available-for-sale, Noncurrent $894.72M.
- 2025-12-31: Debt Securities, Available-for-sale, Noncurrent $771.16M.
- 2025-09-30: Debt Securities, Available-for-sale, Noncurrent $473.06M.
| Period end | Debt Securities, Available-for-sale, Noncurrent | Debt Securities, Available-for-sale, Noncurrent as first filed |
|---|---|---|
| 2026-06-30 | $813.90M 10-Q · filed 2026-08-05 | |
| 2026-03-31 | $894.72M 10-Q · filed 2026-04-30 | |
| 2025-12-31 | $771.16M 10-Q · filed 2026-08-05 | |
| 2025-09-30 | $473.06M 10-Q · filed 2025-11-04 | |
| 2025-06-30 | $297.63M 10-Q · filed 2025-08-11 | |
| 2025-03-31 | $312.33M 10-Q · filed 2025-05-09 | |
| 2024-12-31 | $362.16M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $361.04M 10-Q · filed 2024-10-31 | |
| 2024-06-30 | $192.44M 10-Q · filed 2024-08-07 | |
| 2024-03-31 | $224.39M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $61.43M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $76.99M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $104.76M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $61.40M 10-Q · filed 2024-05-02 | $119.02M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $152.33M 10-K · filed 2024-02-22 | |
| 2022-09-30 | $113.70M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $90.18M 10-Q · filed 2022-08-09 | |
| 2022-03-31 | $102.48M 10-Q · filed 2022-05-03 | |
| 2021-12-31 | $125.19M 10-K · filed 2023-02-23 | |
| 2021-09-30 | $74.69M 10-Q · filed 2021-11-10 | |
| 2021-06-30 | $45.30M 10-Q · filed 2021-08-06 | |
| 2021-03-31 | $101.64M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $162.53M 10-K · filed 2022-02-24 | |
| 2020-09-30 | $187.46M 10-Q · filed 2020-11-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |